Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PPIs: community pharmacists' compliance

E R Kaczmarek, J E Stewart, R A Hutchinson

    Drug Intelligence & Clinical Pharmacy
    |February 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Case of Apoplectic Chill, Acute Rheumatism, and Paralysis Combined.

    Western journal of medicine and surgery·2024
    Same author

    Community scientists produce open data for understanding insects and climate change.

    Current opinion in insect science·2023
    Same author

    Intravenous antibiotics in preterm infants have a negative effect upon microbiome development throughout preterm life.

    Gut pathogens·2023
    Same author

    Fusarioid community diversity associated with conifer seedlings in forest nurseries across the contiguous USA.

    Frontiers in plant science·2023
    Same author

    First Report of <i>Biscogniauxia mediterranea</i> on <i>Quercus emoryi</i> in Southern Arizona.

    Plant disease·2021
    Same author

    Dietary supplementation with phytochemicals improves diversity and abundance of honey bee gut microbiota.

    Journal of applied microbiology·2020

    Community pharmacists showed low compliance with FDA Patient Package Insert (PPI) regulations for estrogen prescriptions. Many dispensed medications without PPIs or safety caps, and few pharmacists could accurately answer patient questions about PPI information.

    Area of Science:

    • Pharmaceutical Sciences
    • Health Policy and Regulation
    • Patient Safety

    Background:

    • The U.S. Food and Drug Administration (FDA) mandates specific regulations for dispensing Patient Package Inserts (PPIs) with certain medications.
    • Estrogen prescriptions are subject to these FDA regulations, requiring the provision of PPIs to patients.
    • Ensuring pharmacist compliance with these regulations is crucial for patient education and medication safety.

    Purpose of the Study:

    • To evaluate community pharmacists' adherence to FDA PPI regulations when dispensing estrogen prescriptions.
    • To assess the accuracy of information provided by pharmacists regarding PPI content.

    Main Methods:

    • A study involving five trained shoppers was conducted across 45 pharmacies in a Midwestern city.

    Related Experiment Videos

  • Shoppers presented estrogen prescriptions to assess dispensing practices.
  • Follow-up phone calls were made to pharmacists to test their knowledge of PPI information.

    • Main Results:

    • Only 42% of dispensed estrogen prescriptions were accompanied by the required PPI.
    • A significant 56% of prescriptions were dispensed without child-resistant safety caps.
    • When asked a question about PPI information, only 39% of pharmacists provided a correct answer.

    Conclusions:

    • Community pharmacists demonstrate suboptimal compliance with FDA PPI regulations for estrogen.
    • Deficiencies in PPI and safety cap dispensing, along with low pharmacist knowledge, pose potential risks to patient safety and informed medication use.